Latest filing published 18 May 2011 for La Jolla Pharmaceutical Co, €414.
Insider track record
No signal scores available.
Deirdre Gillespie: trading record in brief
Filings by Deirdre Gillespie span 2 companies, the busiest being Seelos Therapeutics, Inc. and La Jolla Pharmaceutical Co. We count 11 filings; the first trade dates from 26 May 2010 and the latest from 3 January 2012.
Every open-market trade on record is a sale: 2 sales worth €3,248. Besides market trades, the filings include 8 share grants and 1 option exercise.
The newest entry dates from 4 January 2012: a share grant of €11k, in Seelos Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Deirdre Gillespie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 99,166 shares@ US$0.006Common StockSEC:0001209191-11-029540:0
- 99,166 shares@ US$0.016Common StockSEC:0001209191-11-029540:1
- 2,505 shares@ US$3.55Common StockSEC:0001144204-11-031006:0
- 4,376 shares@ US$0.70Common StockSEC:0001209191-11-023717:0
- 1,961 shares@ US$4.59Common StockSEC:0001144204-11-001385:0
- 654 shares@ US$4.59Common StockSEC:0001144204-10-036346:0
- 437,649 shares@ US$0.03Common StockSEC:0001209191-10-031108:0
7 of 7 declarations
